Ann F Mohrbacher
Medical Director, Autologous Bone Marrow Transplant
Contact
American Society of Clinical Oncology: Career Development Award, 1995
Harvard University : A.B. Magna Cum Laude, 1983
Harvard University: Scholarship, 1983
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study Blood Adv. 2022 02 22; 6(4):1232-1242. . View in PubMed
Secondary haematologic malignancies in women with ovarian cancer receiving poly-ADP ribose polymerase inhibitor therapy Eur J Cancer. 2021 11; 157:59-62. . View in PubMed
The Emergence of Epstein-Barr Virus-Related Diffuse Large B-Cell Lymphoma With Mogamulizumab World J Oncol. 2020 Feb; 11(1):41-43. . View in PubMed
Variability in Cytogenetic Testing for Multiple Myeloma: A Comprehensive Analysis From Across the United States JCO Oncol Pract. 2020 10; 16(10):e1169-e1180. . View in PubMed
A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry Blood Adv. 2020 01 14; 4(1):181-190. . View in PubMed
HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest Group JAMA Oncol. 2018 Jan 01; 4(1):54-62. . View in PubMed
Unrelated HLA mismatched microtransplantation in a patient with refractory secondary acute myeloid leukemia Leuk Res Rep. 2018; 9:18-20. . View in PubMed
Asian-variant intravascular large B-cell lymphoma Proc (Bayl Univ Med Cent). 2017 Apr; 30(2):186-189. . View in PubMed
Toxicity profile of repeated doses of PEG-asparaginase incorporated into a pediatric-type regimen for adult acute lymphoblastic leukemia Eur J Haematol. 2016 Apr; 96(4):375-80. . View in PubMed
A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci Cancer Epidemiol Biomarkers Prev. 2016 12; 25(12):1609-1618. . View in PubMed
Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM Blood. 2016 06 09; 127(23):2833-40. . View in PubMed
An effective reinduction regimen for first relapse of adult acute lymphoblastic leukemia Med Oncol. 2013 Dec; 30(4):744. . View in PubMed
A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma Blood. 2012 Jul 19; 120(3):552-9. . View in PubMed
Phase I trial of anti-CS1 monoclonal antibody elotuzumab in combination with bortezomib in the treatment of relapsed/refractory multiple myeloma J Clin Oncol. 2012 Jun 01; 30(16):1960-5. . View in PubMed
Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial Br J Haematol. 2011 Aug; 154(4):533-5. . View in PubMed
Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma Cancer Chemother Pharmacol. 2011 Jan; 67(1):57-67. . View in PubMed
A phase I biological study of azacitidine (Vidaza™) to determine the optimal dose to inhibit DNA methylation Epigenetics. 2010 Nov-Dec; 5(8):750-7. . View in PubMed
Therapy-related, mixed-lineage leukaemia translocation-positive, monoblastic myeloid sarcoma of the uterus J Clin Pathol. 2007 May; 60(5):562-4. . View in PubMed
Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a Phase III multicenter randomized trial Cancer. 2006 Feb 15; 106(4):848-58. . View in PubMed
B cell non-Hodgkin's lymphoma: rituximab safety experience Arthritis Res Ther. 2005; 7 Suppl 3:S19-25. . View in PubMed
TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities Transfusion. 2003 May; 43(5):641-5. . View in PubMed
Liposomal daunorubicin (DaunoXome) plus dexamethasone for patients with multiple myelomaA phase II International Oncology Study Group study. Cancer. 2002 May 15; 94(10):2645-52. . View in PubMed
Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia: biological implications Blood. 2000 May 01; 95(9):2990-2. . View in PubMed
Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: results of a phase II trial of rituximab J Clin Oncol. 1999 Jun; 17(6):1851-7. . View in PubMed
The influence of patient-related factors on ex vivo retroviral-mediated gene transfer into mobilized peripheral blood myeloid progenitors Hum Gene Ther. 1998 May 01; 9(7):1061-8. . View in PubMed
High-dose chemotherapy and autologous bone marrow plus peripheral blood stem cell transplantation for patients with lymphoma or metastatic breast cancer: use of marker genes to investigate hematopoietic reconstitution in adults Hum Gene Ther. 1996 Mar 20; 7(5):669-84. . View in PubMed
Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion Blood. 1993 Dec 15; 82(12):3712-20. . View in PubMed
Regulation of c-jun gene expression in human T lymphocytes Blood. 1993 Mar 15; 81(6):1540-8. . View in PubMed
Role of interleukin 6 in the growth of myeloma-derived cell lines Leuk Res. 1992 Oct; 16(10):951-9. . View in PubMed
